INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY

A key role of T cells in viral elimination and absence of strong T cell responses in patients with chronic hepatitis C virus (HCV) infection presumes that activation of antigen-specific T cells may be a promising approach to enhance treatment efficacy. Given the central role of dendritic cells (...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, Yu. D. Kurochkina, N. M. Starostina, А. А. Ostanin
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2017
Materias:	chronic hcv infection antigen-specific t cell response core antigen ns3 antigen immunotherapy dendritic cells Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/8264f161056a4ce5bd4969565088d3b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8264f161056a4ce5bd4969565088d3b4
record_format	dspace
spelling	oai:doaj.org-article:8264f161056a4ce5bd4969565088d3b42021-11-18T08:03:46ZINDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY1563-06252313-741X10.15789/1563-0625-2017-4-387-400https://doaj.org/article/8264f161056a4ce5bd4969565088d3b42017-08-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1310https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XA key role of T cells in viral elimination and absence of strong T cell responses in patients with chronic hepatitis C virus (HCV) infection presumes that activation of antigen-specific T cells may be a promising approach to enhance treatment efficacy. Given the central role of dendritic cells (DCs) in the induction of T cell response, the aim of our study was to evaluate effects of DC immunotherapy upon immunological parameters in chronic HCV infection. Ten patients with chronic hepatitis C (genotype 1) were vaccinated with monocytederived DCs, generated in presence of IFNα (IFN-DCs) and pulsed with recombinant HCV Core (1–120) and NS3 (1192–1457) proteins. The vaccination protocol included as initiating procedure (one injection per week, ns = 4) and maintaining treatment (one monthly injection, ns = 6), with subsequent follow up for 6 months. The immunotherapy was not associated with serious adverse events, significant post-vaccination reactions, or increased hepatitis C activity, according to biochemical tests. Ex vivo studies have shown that immunotherapy elicited strong and stable immune response to Core and moderate response to NS3 protein, which manifested as a significant increase of MNC proliferation and IFNγ production in response to Core and enhancement of IFNγ production (without higher proliferation rates), in response to NS3. DC immunotherapy also led to increase of ConA-induced MNC proliferation up to normal levels indicating a recovery of mitogenic T cell reactivity. Meanwhile, T cell activation did not elicit antigen-specific Th2 response and expansion of CD4+CD25+CD127 regulatory T cells. Despite induced immune response, the immunotherapy with DCs was not accompanied by decreased viremia levels. Nevertheless, a transitory decrease of viral load in four patients and stable decrease of viremia in two patients as well as an inverse correlation between NS3-specific proliferation and viremia (Rss = 0.62; p < 0.05) by the end of 6-month follow-up indicated that the antigenspecific T cells may have a potential to control viral replication.E. R. ChernykhE. A. OleynikO. Yu. LeplinaM. A. TikhonovaYu. D. KurochkinaN. M. StarostinaА. А. OstaninSPb RAACIarticlechronic hcv infectionantigen-specific t cell responsecore antigenns3 antigenimmunotherapydendritic cellsImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 19, Iss 4, Pp 387-400 (2017)
institution	DOAJ
collection	DOAJ
language	RU
topic	chronic hcv infection antigen-specific t cell response core antigen ns3 antigen immunotherapy dendritic cells Immunologic diseases. Allergy RC581-607
spellingShingle	chronic hcv infection antigen-specific t cell response core antigen ns3 antigen immunotherapy dendritic cells Immunologic diseases. Allergy RC581-607 E. R. Chernykh E. A. Oleynik O. Yu. Leplina M. A. Tikhonova Yu. D. Kurochkina N. M. Starostina А. А. Ostanin INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
description	A key role of T cells in viral elimination and absence of strong T cell responses in patients with chronic hepatitis C virus (HCV) infection presumes that activation of antigen-specific T cells may be a promising approach to enhance treatment efficacy. Given the central role of dendritic cells (DCs) in the induction of T cell response, the aim of our study was to evaluate effects of DC immunotherapy upon immunological parameters in chronic HCV infection. Ten patients with chronic hepatitis C (genotype 1) were vaccinated with monocytederived DCs, generated in presence of IFNα (IFN-DCs) and pulsed with recombinant HCV Core (1–120) and NS3 (1192–1457) proteins. The vaccination protocol included as initiating procedure (one injection per week, ns = 4) and maintaining treatment (one monthly injection, ns = 6), with subsequent follow up for 6 months. The immunotherapy was not associated with serious adverse events, significant post-vaccination reactions, or increased hepatitis C activity, according to biochemical tests. Ex vivo studies have shown that immunotherapy elicited strong and stable immune response to Core and moderate response to NS3 protein, which manifested as a significant increase of MNC proliferation and IFNγ production in response to Core and enhancement of IFNγ production (without higher proliferation rates), in response to NS3. DC immunotherapy also led to increase of ConA-induced MNC proliferation up to normal levels indicating a recovery of mitogenic T cell reactivity. Meanwhile, T cell activation did not elicit antigen-specific Th2 response and expansion of CD4+CD25+CD127 regulatory T cells. Despite induced immune response, the immunotherapy with DCs was not accompanied by decreased viremia levels. Nevertheless, a transitory decrease of viral load in four patients and stable decrease of viremia in two patients as well as an inverse correlation between NS3-specific proliferation and viremia (Rss = 0.62; p < 0.05) by the end of 6-month follow-up indicated that the antigenspecific T cells may have a potential to control viral replication.
format	article
author	E. R. Chernykh E. A. Oleynik O. Yu. Leplina M. A. Tikhonova Yu. D. Kurochkina N. M. Starostina А. А. Ostanin
author_facet	E. R. Chernykh E. A. Oleynik O. Yu. Leplina M. A. Tikhonova Yu. D. Kurochkina N. M. Starostina А. А. Ostanin
author_sort	E. R. Chernykh
title	INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
title_short	INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
title_full	INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
title_fullStr	INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
title_full_unstemmed	INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY
title_sort	induction of t-cell immune response in chronic hcv-infected patients with underlying dendritic cell immunotherapy
publisher	SPb RAACI
publishDate	2017
url	https://doaj.org/article/8264f161056a4ce5bd4969565088d3b4
work_keys_str_mv	AT erchernykh inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT eaoleynik inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT oyuleplina inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT matikhonova inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT yudkurochkina inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT nmstarostina inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy AT aaostanin inductionoftcellimmuneresponseinchronichcvinfectedpatientswithunderlyingdendriticcellimmunotherapy
_version_	1718422362855047168

INDUCTION OF T-CELL IMMUNE RESPONSE IN CHRONIC HCV-INFECTED PATIENTS WITH UNDERLYING DENDRITIC CELL IMMUNOTHERAPY

Ejemplares similares